Search
for

    Sort by

    Research 451–480 of 1000+

    1. Role of 5 alpha-reductase inhibitors in the management of prostate cancer Clinical interventions in aging · 2006 · 15 citations
    2. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    3. Bioavailability File: Bicalutamide Fabad Journal of Pharmaceutical Sciences · 2025
    4. mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia International Journal of Molecular Sciences · 2023
    5. Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis Infectious Agents and Cancer · 2021 · 9 citations
    6. Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines European Journal of Pharmacology · 2022 · 1 citations
    7. Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization Prostate international · 2024
    8. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021
    9. Characteristics of flutamide action on prostatic and testicular functions in the rat Journal of Steroid Biochemistry · 1988 · 30 citations
    10. Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer Medical Oncology · 2013 · 6 citations
    11. Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis European Urology Focus · 2026
    12. Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis Cancers · 2025
    13. Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats Naunyn-Schmiedeberg s Archives of Pharmacology · 2025
    14. The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them? MAEDICA – a Journal of Clinical Medicine · 2025
    15. The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A Scientific Reports · 2020 · 20 citations
    16. Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth Evidence-based complementary and alternative medicine · 2016 · 6 citations
    17. Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent HAMDAN MEDICAL JOURNAL · 2021
    18. Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer Journal of the American Heart Association · 2021 · 8 citations
    19. 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review European Urology · 2023 · 710 citations
    20. Endocrinology of the Aging Prostate: Current Concepts Frontiers in Endocrinology · 2021 · 21 citations
    21. Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France BMC Cancer · 2014 · 27 citations
    22. Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma Cell Evidence-based Complementary and Alternative Medicine · 2015 · 6 citations
    23. The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer 2008 · 108 citations
    24. Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer Cancers · 2024
    25. Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment F1000Research · 2021 · 8 citations
    26. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation Frontiers in Immunology · 2024 · 18 citations
    27. Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved] Faculty of 1000 Research Ltd · 2021
    28. Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer Current Oncology · 2024 · 6 citations
    29. Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids Biosensors · 2022 · 2 citations
    30. Study Answers Some Questions about Androgen Suppression Pre-Radiation, but Not All Oncology Times · 2015